Percent of products that met Predicted No-Effect Concentrations (PNECs) targets

Unit

i
: Percentage (%)

Indicator

i
: Pollutants released to environment

Metric type

i
: Pressure

Framework alignment notes

i
Refer to Progress Survey Results for related metric Refer to AMR's Shared Goals in the Guidance tab
WHO guidance
Refer to EFPIA's Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement (10.06.24) for alignment to metric
T7

Target example

[Company name] will assess [target amount] of [products] against the Predicted No‐Effect Concentrations (PNECs) targets, in line the approach developed by AMR Industry Alliance.

Target Source: WBCSD target template

Sector

i
Pharmaceutical

Value chain stage

i
Raw Materials Manufacturing End of Life

Metric assessment

i

Relevance: High

Feasibility: Low

Related actions

Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites

Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce air, water and soil pollution (including non-GHG emissions) from agriculture-related pharmaceutical manufacturing feedstocks by engaging with suppliers and encouraging the adoption of less polluting methods in alignment with a Science Based Targets Network (SBTN) Landscape Engagement Target

Reduce air, water and soil pollution (including non-GHG emissions) from agriculture-related pharmaceutical manufacturing feedstocks by engaging with suppliers and encouraging the adoption of less polluting methods in alignment with a Science Based Targets Network (SBTN) Landscape Engagement Target

Description

Value chain stage

Raw Materials

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce APIs (including antibiotics) in the environment by investing in and supporting the development of technologies that enhance the removal of pharmaceutical residues from wastewater

Reduce APIs (including antibiotics) in the environment by investing in and supporting the development of technologies that enhance the removal of pharmaceutical residues from wastewater

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon